Skip to main content

Michael Bittner, Spyro Mousses, Pamela Pollock, Jeff Touchman, Jeffrey Trent, Dietrich Stephan, Edward Suh, Michael Berens, Gregory Kinch


TGen, Arizona’s new Translational Genomics Research Institute, has filled out its staff with 23 additional scientists, research assistants, and technicians, according to a company spokeswoman.

Four of these scientists — Michael Bittner, Spyro Mousses, Pamela Pollock, and Jeff Touchman — come from the NHGRI, where TGen director Jeffrey Trent was scientific director before leaving last June.

Bittner has been appointed senior research investigator in bioinformatics and will use informatics to study cell pathogenesis in silico.

Mousses will run TGen’s cancer drug-development laboratory. He has published recently on the use of microarrays for gene-expression analysis in prostate cancer and prostate-cancer therapy.

Pollock, TGen’s new associate investigator for melanoma research, will spend his time focusing on the factors that cause melanomas to develop. She previously worked in the cancer genetics branch at NHGRI.

Touchman, who will be the executive director of the DNA sequencing core, previously ran a sequencing center at NHGRI.

TGen has also appointed Dietrich Stephan as a senior research investigator and director of its neurogenomics program. Stephan previously served as co-director of Johns Hopkins’ University’s Children’s National Medical Center Microarray Center.

Additionally, Edward Suh, formerly of MIT and the NHGRI, is the CIO of TGen’s Center for Computational Bioscience, and Michael Berens, who has been a principal investigator in neuro-oncology at Phoenix’s Barrow Neurological Institute, will be the institute’s vice president of research.

Microarray software maker Silicon Genetics has appointed Gregory Kinch as vice president of sales and services.

Kinch comes to the Redwood City, Calif.-based company from Genomic Solutions, now a unit of Harvard Bioscience, where he was executive vice president of sales and marketing.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.